• Latest Posts
In Depth 5 Oct 2023

Saving lives with xenotransplantation: how biotechs are solving the transplant shortage crisis

In Depth 4 Oct 2023

CAR-NK: Can natural killer cell therapy pick up from where CAR-T left off?

In Depth 2 Oct 2023

PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay?

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

ADVERTISEMENT
In Depth 14 Sep 2023

Righting wrongs: genetic justice for Henrietta Lacks  

In Depth 11 Sep 2023

Evolving biotech funding trends: VCs lead new series B deals, but early-stage deals require insider support

In Depth 8 Sep 2023

The rise of lab-grown dairy: a sustainable solution for the future

In Depth 7 Sep 2023

Hope for patients with life-threatening muscle disorder after years of clinical trial failures

In Depth 4 Sep 2023

The biggest private biotech investments in August 2023

In Depth 31 Aug 2023

3D-printed tumors: startup hopes to drive cancer drug discovery

ADVERTISEMENT